Meclofenamic acid
- Generic Name
- Meclofenamic acid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H11Cl2NO2
- CAS Number
- 644-62-2
- Unique Ingredient Identifier
- 48I5LU4ZWD
- Background
A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
- Indication
For the relief of mild to moderate pain, for the treatment of primary dysmenorrhea and for the treatment of idiopathic heavy menstrual blood loss. Also for relief of the signs and symptoms of acute and chronic rheumatoid arthritis and osteoarthritis.
- Associated Conditions
- Acute Gouty Arthritis, Ankylosing Spondylitis (AS), Fever, Hypermenorrhea, Juvenile Idiopathic Arthritis (JIA), Mild pain, Osteoarthritis (OA), Primary Dysmenorrhoea, Rheumatoid Arthritis, Acute Subacromial bursitis, Moderate Pain, Supraspinatus tendinitis
- Associated Therapies
- -
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
- Conditions
- SchizophreniaPsychotic DisordersSchizoaffective DisorderBipolar Disorder
- Interventions
- Drug: Pentosan polysulfate sodiumDrug: Meclofenamic acid
- First Posted Date
- 2016-10-11
- Last Posted Date
- 2019-03-26
- Lead Sponsor
- The University of Texas Health Science Center, Houston
- Target Recruit Count
- 8
- Registration Number
- NCT02930005
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary
- Conditions
- Recurrent Brain MetastasesProgressive Brain Metastases
- Interventions
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT02429570
- Locations
- 🇺🇸
Baptist Health South Florida, Miami, Florida, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.